SCAND1 Antibodies

Santa Cruz Biotechnology delivers a wide array of SCAND1 monoclonal antibodies for investigating SCAND1's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SCAND1, or S-phase cyclin A-associated protein, plays a vital role in regulating cell cycle progression and maintaining genomic stability. Research has shown SCAND1's significant involvement in DNA repair mechanisms, making it particularly relevant for cancer studies and therapeutic development. Understanding SCAND1 function continues to reveal new insights into tumorigenesis and potential treatment approaches. Researchers worldwide are actively exploring SCAND1's molecular mechanisms and its impact on cell cycle regulation. Current studies focus on how SCAND1 interacts with other proteins to maintain cellular homeostasis. Ongoing investigations aim to uncover SCAND1's potential as a therapeutic target in various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of SCAND1's role in human health and disease.